Loading…

Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study

European Latin countries have some similarities in their health systems. It is thus interesting to look at their differences in cancer survival (here, ovarian cancer) through monitoring of specific indicators of quality care. The aim of this SUDCAN collaborative study was to compare the trends in 1...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer prevention 2017-01, Vol.26, p.107-113
Main Authors: Chirlaque, María-Dolores, Uhry, Zoé, Salmerón, Diego, Sánchez-Zapata, María-Isabel, Zannoni, Gian Franco, Navarro, Carmen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c329t-f6fb511bca881d1b333b44ce61126e0b386f3df191abdd6d68fe0d4d0fc99d353
cites cdi_FETCH-LOGICAL-c329t-f6fb511bca881d1b333b44ce61126e0b386f3df191abdd6d68fe0d4d0fc99d353
container_end_page 113
container_issue
container_start_page 107
container_title European journal of cancer prevention
container_volume 26
creator Chirlaque, María-Dolores
Uhry, Zoé
Salmerón, Diego
Sánchez-Zapata, María-Isabel
Zannoni, Gian Franco
Navarro, Carmen
description European Latin countries have some similarities in their health systems. It is thus interesting to look at their differences in cancer survival (here, ovarian cancer) through monitoring of specific indicators of quality care. The aim of this SUDCAN collaborative study was to compare the trends in 1 and 5-year net survival from ovarian cancer and the trends in the excess mortality rates between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland). The data were extracted from the EUROCARE-5 database. First, the net survival was studied over the 2000–2004 period using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland, and from 2000 to 2004 in Belgium and Portugal. The analyses were carried out using a flexible excess rate modelling. Over the period 2000–2004, there were slight differences in the 5-year age-standardized net survivals from ovarian cancer; they ranged from 36% in Spain to 42% in Belgium. Net survival was much higher in young than in old age groups, but this difference was more marked in Spain and less marked in France. Between 1992 and 2004, the net survival increased in all countries, mainly in young and middle-aged women. However, the differences in 5-year net survival between these countries were larger in 2004 than in 1992. Slight differences were observed in survival from ovarian cancer between the six European Latin countries. A considerable improvement in survival was observed in all countries, especially in young and middle-aged women. This study highlights the need for further monitoring of ovarian cancer outcomes.
doi_str_mv 10.1097/CEJ.0000000000000302
format article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1852779270</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>48504534</jstor_id><sourcerecordid>48504534</sourcerecordid><originalsourceid>FETCH-LOGICAL-c329t-f6fb511bca881d1b333b44ce61126e0b386f3df191abdd6d68fe0d4d0fc99d353</originalsourceid><addsrcrecordid>eNpdkE1Lw0AQhhdRbK3-A5UcvaTOZr-PUupHKXip57DZD0hJs3U3KfrvTWkt4lwGZp53Bh6EbjFMMSjxOJsvpvC3CBRnaIypIDkToM7RGBRTuSyEHKGrlNYAWBDML9GokACMYzJGi1V0rU1Z3Wat67LUx129003mY9hkYadjrdvM6Na4uGdS_ZXN-xi2bhgvdTeMTOjbLtYuXaMLr5vkbo59gj6e56vZa758f3mbPS1zQwrV5Z77imFcGS0ltrgihFSUGscxLriDikjuifVYYV1Zyy2X3oGlFrxRyhJGJujhcHcbw2fvUldu6mRc0-jWhT6VWLJCCFUIGFB6QE0MKUXny22sNzp-lxjKvcVysFj-tzjE7o8f-mrj7Cn0q20A7g7AOnUhnvZUMqCMUPIDwpZ2wg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1852779270</pqid></control><display><type>article</type><title>Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study</title><source>JSTOR Archival Journals and Primary Sources Collection</source><creator>Chirlaque, María-Dolores ; Uhry, Zoé ; Salmerón, Diego ; Sánchez-Zapata, María-Isabel ; Zannoni, Gian Franco ; Navarro, Carmen</creator><creatorcontrib>Chirlaque, María-Dolores ; Uhry, Zoé ; Salmerón, Diego ; Sánchez-Zapata, María-Isabel ; Zannoni, Gian Franco ; Navarro, Carmen ; GRELL EUROCARE-5 Working Group ; GRELL EUROCARE-5 Working Group</creatorcontrib><description>European Latin countries have some similarities in their health systems. It is thus interesting to look at their differences in cancer survival (here, ovarian cancer) through monitoring of specific indicators of quality care. The aim of this SUDCAN collaborative study was to compare the trends in 1 and 5-year net survival from ovarian cancer and the trends in the excess mortality rates between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland). The data were extracted from the EUROCARE-5 database. First, the net survival was studied over the 2000–2004 period using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland, and from 2000 to 2004 in Belgium and Portugal. The analyses were carried out using a flexible excess rate modelling. Over the period 2000–2004, there were slight differences in the 5-year age-standardized net survivals from ovarian cancer; they ranged from 36% in Spain to 42% in Belgium. Net survival was much higher in young than in old age groups, but this difference was more marked in Spain and less marked in France. Between 1992 and 2004, the net survival increased in all countries, mainly in young and middle-aged women. However, the differences in 5-year net survival between these countries were larger in 2004 than in 1992. Slight differences were observed in survival from ovarian cancer between the six European Latin countries. A considerable improvement in survival was observed in all countries, especially in young and middle-aged women. This study highlights the need for further monitoring of ovarian cancer outcomes.</description><identifier>ISSN: 0959-8278</identifier><identifier>EISSN: 1473-5709</identifier><identifier>DOI: 10.1097/CEJ.0000000000000302</identifier><identifier>PMID: 28005613</identifier><language>eng</language><publisher>England: Lippincott Williams &amp; Wilkins, a business of Wolters Kluwer Health</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Belgium - epidemiology ; Databases, Factual - trends ; Europe - epidemiology ; Female ; France - epidemiology ; Humans ; Italy - epidemiology ; Middle Aged ; Ovarian Neoplasms - diagnosis ; Ovarian Neoplasms - mortality ; Population Surveillance - methods ; Portugal - epidemiology ; Registries ; Spain - epidemiology ; Supplement article ; Survival Rate - trends ; Switzerland - epidemiology ; Young Adult</subject><ispartof>European journal of cancer prevention, 2017-01, Vol.26, p.107-113</ispartof><rights>Copyright © 2017 Wolters Kluwer Health, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c329t-f6fb511bca881d1b333b44ce61126e0b386f3df191abdd6d68fe0d4d0fc99d353</citedby><cites>FETCH-LOGICAL-c329t-f6fb511bca881d1b333b44ce61126e0b386f3df191abdd6d68fe0d4d0fc99d353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/48504534$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/48504534$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28005613$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chirlaque, María-Dolores</creatorcontrib><creatorcontrib>Uhry, Zoé</creatorcontrib><creatorcontrib>Salmerón, Diego</creatorcontrib><creatorcontrib>Sánchez-Zapata, María-Isabel</creatorcontrib><creatorcontrib>Zannoni, Gian Franco</creatorcontrib><creatorcontrib>Navarro, Carmen</creatorcontrib><creatorcontrib>GRELL EUROCARE-5 Working Group</creatorcontrib><creatorcontrib>GRELL EUROCARE-5 Working Group</creatorcontrib><title>Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study</title><title>European journal of cancer prevention</title><addtitle>Eur J Cancer Prev</addtitle><description>European Latin countries have some similarities in their health systems. It is thus interesting to look at their differences in cancer survival (here, ovarian cancer) through monitoring of specific indicators of quality care. The aim of this SUDCAN collaborative study was to compare the trends in 1 and 5-year net survival from ovarian cancer and the trends in the excess mortality rates between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland). The data were extracted from the EUROCARE-5 database. First, the net survival was studied over the 2000–2004 period using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland, and from 2000 to 2004 in Belgium and Portugal. The analyses were carried out using a flexible excess rate modelling. Over the period 2000–2004, there were slight differences in the 5-year age-standardized net survivals from ovarian cancer; they ranged from 36% in Spain to 42% in Belgium. Net survival was much higher in young than in old age groups, but this difference was more marked in Spain and less marked in France. Between 1992 and 2004, the net survival increased in all countries, mainly in young and middle-aged women. However, the differences in 5-year net survival between these countries were larger in 2004 than in 1992. Slight differences were observed in survival from ovarian cancer between the six European Latin countries. A considerable improvement in survival was observed in all countries, especially in young and middle-aged women. This study highlights the need for further monitoring of ovarian cancer outcomes.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Belgium - epidemiology</subject><subject>Databases, Factual - trends</subject><subject>Europe - epidemiology</subject><subject>Female</subject><subject>France - epidemiology</subject><subject>Humans</subject><subject>Italy - epidemiology</subject><subject>Middle Aged</subject><subject>Ovarian Neoplasms - diagnosis</subject><subject>Ovarian Neoplasms - mortality</subject><subject>Population Surveillance - methods</subject><subject>Portugal - epidemiology</subject><subject>Registries</subject><subject>Spain - epidemiology</subject><subject>Supplement article</subject><subject>Survival Rate - trends</subject><subject>Switzerland - epidemiology</subject><subject>Young Adult</subject><issn>0959-8278</issn><issn>1473-5709</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpdkE1Lw0AQhhdRbK3-A5UcvaTOZr-PUupHKXip57DZD0hJs3U3KfrvTWkt4lwGZp53Bh6EbjFMMSjxOJsvpvC3CBRnaIypIDkToM7RGBRTuSyEHKGrlNYAWBDML9GokACMYzJGi1V0rU1Z3Wat67LUx129003mY9hkYadjrdvM6Na4uGdS_ZXN-xi2bhgvdTeMTOjbLtYuXaMLr5vkbo59gj6e56vZa758f3mbPS1zQwrV5Z77imFcGS0ltrgihFSUGscxLriDikjuifVYYV1Zyy2X3oGlFrxRyhJGJujhcHcbw2fvUldu6mRc0-jWhT6VWLJCCFUIGFB6QE0MKUXny22sNzp-lxjKvcVysFj-tzjE7o8f-mrj7Cn0q20A7g7AOnUhnvZUMqCMUPIDwpZ2wg</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Chirlaque, María-Dolores</creator><creator>Uhry, Zoé</creator><creator>Salmerón, Diego</creator><creator>Sánchez-Zapata, María-Isabel</creator><creator>Zannoni, Gian Franco</creator><creator>Navarro, Carmen</creator><general>Lippincott Williams &amp; Wilkins, a business of Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170101</creationdate><title>Trends in net survival from ovarian cancer in six European Latin countries</title><author>Chirlaque, María-Dolores ; Uhry, Zoé ; Salmerón, Diego ; Sánchez-Zapata, María-Isabel ; Zannoni, Gian Franco ; Navarro, Carmen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c329t-f6fb511bca881d1b333b44ce61126e0b386f3df191abdd6d68fe0d4d0fc99d353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Belgium - epidemiology</topic><topic>Databases, Factual - trends</topic><topic>Europe - epidemiology</topic><topic>Female</topic><topic>France - epidemiology</topic><topic>Humans</topic><topic>Italy - epidemiology</topic><topic>Middle Aged</topic><topic>Ovarian Neoplasms - diagnosis</topic><topic>Ovarian Neoplasms - mortality</topic><topic>Population Surveillance - methods</topic><topic>Portugal - epidemiology</topic><topic>Registries</topic><topic>Spain - epidemiology</topic><topic>Supplement article</topic><topic>Survival Rate - trends</topic><topic>Switzerland - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chirlaque, María-Dolores</creatorcontrib><creatorcontrib>Uhry, Zoé</creatorcontrib><creatorcontrib>Salmerón, Diego</creatorcontrib><creatorcontrib>Sánchez-Zapata, María-Isabel</creatorcontrib><creatorcontrib>Zannoni, Gian Franco</creatorcontrib><creatorcontrib>Navarro, Carmen</creatorcontrib><creatorcontrib>GRELL EUROCARE-5 Working Group</creatorcontrib><creatorcontrib>GRELL EUROCARE-5 Working Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer prevention</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chirlaque, María-Dolores</au><au>Uhry, Zoé</au><au>Salmerón, Diego</au><au>Sánchez-Zapata, María-Isabel</au><au>Zannoni, Gian Franco</au><au>Navarro, Carmen</au><aucorp>GRELL EUROCARE-5 Working Group</aucorp><aucorp>GRELL EUROCARE-5 Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study</atitle><jtitle>European journal of cancer prevention</jtitle><addtitle>Eur J Cancer Prev</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>26</volume><spage>107</spage><epage>113</epage><pages>107-113</pages><issn>0959-8278</issn><eissn>1473-5709</eissn><abstract>European Latin countries have some similarities in their health systems. It is thus interesting to look at their differences in cancer survival (here, ovarian cancer) through monitoring of specific indicators of quality care. The aim of this SUDCAN collaborative study was to compare the trends in 1 and 5-year net survival from ovarian cancer and the trends in the excess mortality rates between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland). The data were extracted from the EUROCARE-5 database. First, the net survival was studied over the 2000–2004 period using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country. The results are reported from 1992 to 2004 in France, Italy, Spain and Switzerland, and from 2000 to 2004 in Belgium and Portugal. The analyses were carried out using a flexible excess rate modelling. Over the period 2000–2004, there were slight differences in the 5-year age-standardized net survivals from ovarian cancer; they ranged from 36% in Spain to 42% in Belgium. Net survival was much higher in young than in old age groups, but this difference was more marked in Spain and less marked in France. Between 1992 and 2004, the net survival increased in all countries, mainly in young and middle-aged women. However, the differences in 5-year net survival between these countries were larger in 2004 than in 1992. Slight differences were observed in survival from ovarian cancer between the six European Latin countries. A considerable improvement in survival was observed in all countries, especially in young and middle-aged women. This study highlights the need for further monitoring of ovarian cancer outcomes.</abstract><cop>England</cop><pub>Lippincott Williams &amp; Wilkins, a business of Wolters Kluwer Health</pub><pmid>28005613</pmid><doi>10.1097/CEJ.0000000000000302</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0959-8278
ispartof European journal of cancer prevention, 2017-01, Vol.26, p.107-113
issn 0959-8278
1473-5709
language eng
recordid cdi_proquest_miscellaneous_1852779270
source JSTOR Archival Journals and Primary Sources Collection
subjects Adolescent
Adult
Aged
Aged, 80 and over
Belgium - epidemiology
Databases, Factual - trends
Europe - epidemiology
Female
France - epidemiology
Humans
Italy - epidemiology
Middle Aged
Ovarian Neoplasms - diagnosis
Ovarian Neoplasms - mortality
Population Surveillance - methods
Portugal - epidemiology
Registries
Spain - epidemiology
Supplement article
Survival Rate - trends
Switzerland - epidemiology
Young Adult
title Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A55%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20net%20survival%20from%20ovarian%20cancer%20in%20six%20European%20Latin%20countries:%20results%20from%20the%20SUDCAN%20population-based%20study&rft.jtitle=European%20journal%20of%20cancer%20prevention&rft.au=Chirlaque,%20Mar%C3%ADa-Dolores&rft.aucorp=GRELL%20EUROCARE-5%20Working%20Group&rft.date=2017-01-01&rft.volume=26&rft.spage=107&rft.epage=113&rft.pages=107-113&rft.issn=0959-8278&rft.eissn=1473-5709&rft_id=info:doi/10.1097/CEJ.0000000000000302&rft_dat=%3Cjstor_proqu%3E48504534%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c329t-f6fb511bca881d1b333b44ce61126e0b386f3df191abdd6d68fe0d4d0fc99d353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1852779270&rft_id=info:pmid/28005613&rft_jstor_id=48504534&rfr_iscdi=true